Man Group
TXG icon

Man Group’s 10x Genomics TXG Stock Holding History

Man Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-269,264
Closed -$5.72M – 2616
2026
Q1 		$5.72M Sell
269,264
-123,800
-31% -$2.47M 0.01% 1086
2025
Q4 		$6.41M Sell
393,064
-201,478
-34% -$3.04M 0.01% 987
2025
Q3 		$6.95M Sell
594,542
-235,068
-28% -$3.06M 0.01% 952
2025
Q2 		$9.61M Buy
829,610
+687,773
+485% +$6.27M 0.02% 794
2025
Q1 		$1.24M Buy
141,837
+15,171
+12% +$191K ﹤0.01% 1521
2024
Q4 		$1.82M Buy
126,666
+55,346
+78% +$873K ﹤0.01% 1337
2024
Q3 		$1.61M Sell
71,320
-35,306
-33% -$730K ﹤0.01% 1377
2024
Q2 		$2.07M Buy
106,626
+62,061
+139% +$1.63M 0.01% 1328
2024
Q1 		$1.67M Sell
44,565
-182,602
-80% -$8.02M ﹤0.01% 1373
2023
Q4 		$12.7M Buy
+227,167
New +$9.88M 0.04% 549
2023
Q3 		– Sell
-195,810
Closed -$10.2M – 442
2023
Q2 		$10.9M Buy
+195,810
New +$10.6M 0.03% 595
2023
Q1 		– Sell
-543,006
Closed -$25.4M – 501
2022
Q4 		$19.8M Buy
+543,006
New +$17.8M 0.07% 344
2022
Q1 		– Sell
-3,085
Closed -$459K – 2373
2021
Q4 		$459K Sell
3,085
-49,009
-94% -$7.51M ﹤0.01% 1560
2021
Q3 		$7.58M Buy
52,094
+25,215
+94% +$4.33M 0.03% 676
2021
Q2 		$5.26M Sell
26,879
-25,814
-49% -$4.67M 0.02% 862
2021
Q1 		$9.54M Sell
52,693
-5,924
-10% -$1.02M 0.04% 449
2020
Q4 		$8.3M Buy
58,617
+2,784
+5% +$404K 0.04% 521
2020
Q3 		$6.96M Sell
55,833
-7,702
-12% -$808K 0.03% 645
2020
Q2 		$5.67M Buy
+63,535
New +$4.95M 0.03% 606

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Man Group's TXG Position: Q2 2026 in Review

Man Group sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 269,264 shares — an estimated $5.72M sold.

Man Group first reported a position in TXG in Q2 2020 and held it in 19 quarters. The position peaked at $19.8M in Q4 2022. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Man Group reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 269,264 10x Genomics shares in Q2 2026, an estimated $5.72M.
  • Man Group first reported a position in 10x Genomics in Q2 2020 and held it in 19 quarters.
  • Man Group's 10x Genomics position peaked at $19.8M in Q4 2022.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.